Market Overview

Why Interpace Biosciences Is Trading Higher Today


Interpace Biosciences (NASDAQ: IDXG) shares are trading higher on Wednesday after an audit committee investigation found that billing and compliance complaints against the company were unsubstantiated and that there was no evidence of any illegal acts.

Interpace Biosciences Inc is a growing leader in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics.

Interpace Biosciences shares traded up 29.87% to $3.87 on Wednesday. The stock has a 52-week high of $11 and a 52-week low of $2.57.


Related Articles (IDXG)

View Comments and Join the Discussion!

Posted-In: why it's movingNews Penny Stocks Legal

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at